XML 72 R56.htm IDEA: XBRL DOCUMENT v3.25.1
Acquisitions, Licensing and Other Arrangements - ObsEva (Details) - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Nov. 21, 2022
Dec. 31, 2023
Dec. 31, 2024
Dec. 31, 2023
Asset acquisition        
Impairment of intangible asset       $ 14,253
Revenue recognized     $ 6,650 2,650
Obseva - Ebopiprant IP        
Asset acquisition        
Impairment of intangible asset       14,253
License Agreement | ObsEva, Organon        
Asset acquisition        
Revenue recognized     $ 0 0
License Agreement | ObsEva, Organon | Obseva - Ebopiprant IP        
Asset acquisition        
Impairment of intangible asset   $ 14,200   $ 14,200
ObsEva IP        
Asset acquisition        
Closing cash payment $ 15,000